688108.SH
赛诺医疗
SSE · Healthcare · Medical - Devices · CN
CNY 17.63
−4.60%Year over year
Reported trailing growth
- Revenue
- +20.4%
- EBITDA
- —
- EBIT
- +2285.7%
- EPS
- +781.0%
- Free cash flow
- +116.0%
- Operating cash flow
- +27.0%
Forward estimates
Based on analyst estimates
- Revenue
- -28.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +39.7%
- EBITDA
- +398.0%
- EBIT
- +493.8%
- Net income
- +3057.1%
- EPS
- +2650.0%
- Free cash flow
- +89.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026